Orion Pharma Limited engages in the creation, discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. The company produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups, such as anticancer, antibiotics, anti-diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. It also provides various vaccines and health-related consumer products, as well as generates and supplies electricity. The company was formerly known as Orion Laboratories Limited and changed its name to Orion Pharma Limited in October 2010. Orion Pharma Limited was incorporated in 1965 and is based in Dhaka, Bangladesh.
Metrics to compare | ORIO | Peers Peers - average of corresponding metrics from companies closely matching ORIO: SILVAPHL, ADVENT, CENTRALPHL, IBP, TECHNODRUG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipORIOPeersSector |
---|---|---|---|---|
P/E Ratio | −67.4x | 17.3x | −0.6x | |
PEG Ratio | 0.55 | −0.59 | 0.00 | |
Price/Book | 0.4x | 1.5x | 2.6x | |
Price / LTM Sales | 1.2x | 2.9x | 3.3x | |
Upside (Analyst Target) | - | 30.0% | 39.1% | |
Fair Value Upside | Unlock | 10.7% | 4.5% | Unlock |